comparemela.com

Page 17 - Erik Manting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunicum AB: Notice of Annual General Meeting in Immunicum AB (publ)

08.04.2022 - Press Release Stockholm, Sweden, April 8, 2022 NOTICE OF ANNUAL GENERAL MEETING IN IMMUNICUM AB (PUBL) The shareholders of Immunicum AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Annual General .

Dharminder chahalJannis kitsakisBrendan payneErik esveldSven andreassonHolger blomstrand byggnadsCharlotte holmstrandMario brkuljHans preustingErik mantingChristine lindAndrea van elsasEuropean parliamentCompany the participantsFourth swedish national pension fundSwedish companies

Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum

Mario brkuljErik mantingBrendan payneSociety for immunotherapy of cancerValency communicationsYear end resultsLotta fermChief financialGastrointestinal stromal tumorsStrategy outlookEnd reportReport januaryGeneral meetingSwedish securities market act

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum

Mario brkuljErik mantingBrendan payneSociety for immunotherapy of cancerValency communicationsLotta fermChief financialGastrointestinal stromal tumorsStrategy outlookEnd reportReport januaryGeneral meetingSwedish securities market act

Investegate |Immunicum AB Announcements | Immunicum AB: Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

Investegate announcements from Immunicum AB, Correction: Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

Mario brkuljErik mantingBrendan payneSociety for immunotherapy of cancerValency communicationsYear end resultsLotta fermChief financialGastrointestinal stromal tumorsStrategy outlookEnd reportReport januaryGeneral meetingSwedish securities market actInvestegate announcementsInvestegate company announcements

Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021

OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK - (-).Result for the period amounted to KSEK -32,844 (-47,880).Earnings and diluted earnings per share totaled SEK -0.16 (-0.58).Immunicum

Mario brkuljErik mantingBrendan payneSociety for immunotherapy of cancerValency communicationsLotta fermChief financialGastrointestinal stromal tumorsStrategy outlookEnd reportReport januaryGeneral meetingSwedish securities market act

vimarsana © 2020. All Rights Reserved.